SVNS — Solvonis Therapeutics Share News
0.000.00%
Last trade - 00:00Solvonis Therapeutic - Update on AWKN-SDN-14 programme
Solvonis Therapeutic - Holding(s) in Company
Solvonis Therapeutic - Appointment of Non-Executive Director
RCS - Solvonis Therapeutic - Presentation at PharmaSynergyRx Event
Solvonis Therapeutic - Entry into an Arrangement Agreement with Awakn
RCS - Solvonis Therapeutic - Proactive Investors interview with Chairman
Solvonis Therapeutic - Update on Awakn Life Sciences’ R&D Progress
RCS - Solvonis Therapeutic - Investor Presentation
RCS - Solvonis Therapeutic - Proactive Investors interview with CEO
Solvonis Therapeutic - Update on FDA Pre-IND Meeting for Awakn
RCS - Solvonis Therapeutic - Interview with CEO
Brief: Graft Polymer(UK)Says Co Has Changed Name To Solvonis Therapeutics
RCS - Graft Polymer (UK) - Proactive Investors Interview with CEO and Chair
Brief: Graft Polymer (UK) Says Awakn Valued At £4.98 Mln In Proposed Acquisition
Graft Polymer (UK) - Proposed acquisition of Awakn Life Sciences Corp
Graft Polymer (UK) - Initial Results University of Nottingham
Brief: Graft Polymer (UK) Proposes Change Of Name To Solvonis Therapeutics Plc
Graft Polymer (UK) - Notice of GM and proposed name change
Graft Polymer (UK) - Research Agreement